Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...
bovnews23h
Regeneron Pharmaceuticals Inc (REGN) Stock: Understanding Its Underlying Value
Regeneron Pharmaceuticals Inc (REGN) stock saw a decline, ending the day at $681.58 which represents a decrease of $-11.65 or -1.68% from the prior close of $693.23. The stock opened at $705.34 and ...
Regeneron Pharmaceuticals, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the REGN Class Action
SAN DIEGO, CA / ACCESSWIRE / January 15, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...